뉴스
- Onconic Surges on Jaqbo’s India Approval[K-Bio Pulse] South Korea’s pharmaceutical and life sciences sectors advanced in tandem on Aug. 6, led by Onconic Therapeutics, Qurient and Voronoi.The pharmaceutical i
- Remedi Surges 23%; Bio Solution Climbs on China Expansion [K-bio pulse] Portable X-ray maker Remedi saw its shares surge after reporting explosive earnings growth. The company is expanding rapidly not only in South Korea but also ov
- FromBio Hits Limit-Up as Trading Resumes; Curacle Surges on Follow-On Licensing Hopes [K-Bio Puls... On Aug. 10, South Korean pharmaceutical and biotech stocks broadly advanced as the KOSDAQ rebounded. FromBio soared to the daily upper limit as trading resumed
- Remedi Surges, HLB Hits Limit Down as FDA Blow Weighs[K-Bio Pulse] The Korean biotech sector saw sharply diverging performances on July 13, with newly listed Remedi. emerging as the day's standout performer, while HLB extended